We are live on ! Find out more
WCBA

Weaver C. Barksdale & Associates Portfolio holdings

AUM $105M
1-Year Est. Return 13.81%
This Fund
S&P 500
This Quarter Est. Return
+3.92%
1 Year Est. Return
+13.81%
3 Year Est. Return
+40.08%
5 Year Est. Return
10 Year Est. Return
AUM
$62M
AUM Growth
+$2.53M
Cap. Flow
+$601K
Cap. Flow %
0.97%
Top 10 Hldgs %
17.86%
Holding
562
New
23
Increased
266
Reduced
152
Closed
30

Top Buys

Rank Stock Value
1
PFG icon
Principal Financial Group
PFG
+$1.05M
2
CVS icon
CVS Health
CVS
+$1.04M
3
MDT icon
Medtronic
MDT
+$916K
4
UPS icon
United Parcel Service
UPS
+$322K
5
NVS icon
Novartis
NVS
+$316K

Top Sells

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$881K
2
GE icon
GE Aerospace
GE
+$831K
3
LLY icon
Eli Lilly
LLY
+$639K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$373K
5
KSS icon
Kohl's
KSS
+$239K

Sector Composition

Rank Sector Weight
1 Technology 15.59%
2 Industrials 14.22%
3 Healthcare 13.42%
4 Financials 12.85%
5 Consumer Discretionary 12.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHC
351
Diversified Healthcare Trust
DHC
$2.04B
$6K 0.01%
337
+109
+48% +$2.11K
EWBC icon
352
East-West Bancorp
EWBC
$18.1B
$6K 0.01%
126
-22
-15% -$978
FDS icon
353
Factset
FDS
$10.1B
$6K 0.01%
39
+9
+30% +$1.44K
FHI icon
354
Federated Hermes
FHI
$4.71B
$6K 0.01%
224
+68
+44% +$1.88K
MSCI icon
355
MSCI
MSCI
$40.9B
$6K 0.01%
80
+17
+27% +$1.37K
NTCT icon
356
NETSCOUT
NTCT
$2.81B
$6K 0.01%
199
+11
+6% +$337
PTC icon
357
PTC
PTC
$16.4B
$6K 0.01%
137
+5
+4% +$234
PTEN icon
358
Patterson-UTI
PTEN
$4.19B
$6K 0.01%
216
-85
-28% -$2.1K
SAM icon
359
Boston Beer
SAM
$1.86B
$6K 0.01%
33
+5
+18% +$828
SM icon
360
SM Energy
SM
$7.55B
$6K 0.01%
174
+21
+14% +$759
SNV
361
DELISTED
Synovus
SNV
$6K 0.01%
156
-9
-5% -$331
PACW
362
DELISTED
PacWest Bancorp
PACW
$6K 0.01%
106
UMPQ
363
DELISTED
Umpqua Holdings Corp
UMPQ
$6K 0.01%
328
-15
-4% -$255
WPX
364
DELISTED
WPX Energy, Inc.
WPX
$6K 0.01%
383
-36
-9% -$476
VSM
365
DELISTED
Versum Materials, Inc.
VSM
$6K 0.01%
+198
New +$4.93K
ATW
366
DELISTED
Atwood Oceanics
ATW
$6K 0.01%
436
+209
+92% +$2.06K
JNS
367
DELISTED
Janus Capital Group Inc
JNS
$6K 0.01%
430
+75
+21% +$1.03K
MENT
368
DELISTED
Mentor Graphics Corp
MENT
$6K 0.01%
171
-63
-27% -$2.06K
SBNY
369
DELISTED
Signature Bank
SBNY
$6K 0.01%
43
ACIW icon
370
ACI Worldwide
ACIW
$5.34B
$5K 0.01%
299
+45
+18% +$842
ANSS
371
DELISTED
Ansys
ANSS
$5K 0.01%
58
+7
+14% +$645
ARE icon
372
Alexandria Real Estate Equities
ARE
$8.32B
$5K 0.01%
48
+9
+23% +$966
ASB icon
373
Associated Banc-Corp
ASB
$5.92B
$5K 0.01%
221
-15
-6% -$330
CMP icon
374
Compass Minerals
CMP
$1.13B
$5K 0.01%
70
CPT icon
375
Camden Property Trust
CPT
$11B
$5K 0.01%
64
+11
+21% +$874

Similar funds

Weaver C. Barksdale & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Weaver C. Barksdale & Associates held 562 positions worth $62M, up 4.2% from $59.5M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Weaver C. Barksdale & Associates's Q4 2016 filing shows 23 new, 266 increased, 152 reduced and 30 closed positions. Its largest new stake was Principal Financial Group: 18,823 shares worth $1.09M. The largest sale was Coca-Cola, an estimated $881K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.

  • Weaver C. Barksdale & Associates's largest Q4 2016 buy was Principal Financial Group: 18,823 shares worth $1.09M.
  • Weaver C. Barksdale & Associates added most to United Parcel Service in Q4 2016, an estimated $322K increase.
  • Weaver C. Barksdale & Associates's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $639K.
  • Weaver C. Barksdale & Associates fully exited Coca-Cola in Q4 2016, selling an estimated $881K.
  • Weaver C. Barksdale & Associates's ten largest holdings make up 18% of its $62M portfolio in Q4 2016.
  • Weaver C. Barksdale & Associates opened 23 new positions and closed 30 in Q4 2016.
  • Weaver C. Barksdale & Associates's portfolio value rose 4.2% quarter-over-quarter to $62M.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2016, filed 26 Jan 2017.